J. V. van Zanden

发表

Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro.

I. Meerts, G. Marsh, A. Bergman, 2000, Toxicological sciences : an official journal of the Society of Toxicology.

The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential.

H. Wortelboer, J. V. van Zanden, N. Cnubben, 2007, Biochemical pharmacology.

Effects of erythropoietin on fibroblast growth factor 23 in mice and humans.

T. Ganz, S. Bakker, J. V. van Zanden, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Screening for M-proteinemia: serum protein electrophoresis and free light chains compared

J. V. van Zanden, A. Bakker, Coby Elderman-van der Werf, 2009, Clinical chemistry and laboratory medicine.

Metabolism of ATP-binding cassette drug transporter inhibitors: complicating factor for multidrug resistance

P. van Bladeren, H. Wortelboer, J. V. van Zanden, 2005, Expert opinion on drug metabolism & toxicology.

Identification of o‐quinone/quinone methide metabolites of quercetin in a cellular in vitro system

P. van Bladeren, J. V. van Zanden, I. Rietjens, 2002, FEBS letters.

The expression of CYP1A, vitellogenin and zona radiata proteins in Atlantic salmon (Salmo salar) after oral dosing with two commercial PBDE flame retardant mixtures: absence of short-term responses.

A. Arukwe, A. Goksøyr, J. V. van Zanden, 2002, Marine environmental research.

The interplay of glutathione-related processes in antioxidant defense.

P. van Bladeren, H. Wortelboer, J. V. van Zanden, 2001, Environmental toxicology and pharmacology.

New diagnostic criteria for gestational diabetes mellitus and their impact on the number of diagnoses and pregnancy outcomes

B. Wolffenbuttel, J. V. van Zanden, K. Hoogenberg, 2017, Diabetologia.

Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha,beta-unsaturated carbonyl compounds.

P. van Bladeren, H. Wortelboer, J. V. van Zanden, 2005, Biochemical pharmacology.

Medicalising pregnancy with new diagnostic criteria for gestational diabetes mellitus: do we need more evidence? Reply to Venkataraman H and Saravanan P [letter]

B. Wolffenbuttel, J. V. van Zanden, K. Hoogenberg, 2018, Diabetologia.

Age dependency of plasma vitamin B12 status markers in Dutch children and adolescents

J. V. van Zanden, M. Heiner-Fokkema, A. M. Muller Kobold, 2021, Pediatric Research.

Tolerance-based capecitabine dose escalation after DPYD genotype-guided dosing in heterozygote DPYD variant carriers: a single-center observational study

J. V. van Zanden, J. V. van Rooijen, Robbert Bakema, 2019, Anti-cancer drugs.

Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin.

P. van Bladeren, J. V. van Zanden, N. Cnubben, 2003, Chemico-biological interactions.

The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids.

J. V. van Zanden, N. Cnubben, J. Koeman, 2002, Environmental toxicology and pharmacology.

Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells.

Liesbeth Geraets, Ivonne M C M Rietjens, Nicole H P Cnubben, 2004, Biochemical pharmacology.

Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetin.

P. van Bladeren, H. Wortelboer, J. V. van Zanden, 2005, Biochemical pharmacology.

An Overview of Innovative Techniques to Improve Cervical Cancer Screening

H. Hollema, E. Schuuring, A. V. D. Van Der Zee, 2006, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.

J. Groten, P. van Bladeren, G. Williamson, 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer

H. Hollema, E. Schuuring, A. V. D. Van Der Zee, 2011, Clinical Cancer Research.

Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2.

Mustafa Usta, Ans Punt, Ivonne M C M Rietjens, 2005, Biochemical pharmacology.

Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population

Lyanne M. Kieneker, I. Nolte, G. Navis, 2021, Journal of the American Heart Association.

Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin.

P. van Bladeren, H. Wortelboer, J. V. van Zanden, 2003, Chemical research in toxicology.

Quantitation of serum free light chains.

J. V. van Zanden, A. Bakker, Coby Elderman-van der Werf, 2009, Clinical chemistry.

Androgens and Development of Posttransplantation Diabetes Mellitus in Male Kidney Transplant Recipients: A Post Hoc Analysis of a Prospective Study

A. V. van Beek, J. V. van Zanden, I. Kema, 2021, Diabetes Care.

Insights uncovered from experiencing a rise in the incidence of gestational diabetes at a Melbourne hospital. Reply to Ng E, Neff M, Sztal-Mazer S [letter]

B. Wolffenbuttel, J. V. van Zanden, A. van Loon, 2018, Diabetologia.

Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha,beta-unsaturated carbonyl compounds.

P. van Bladeren, H. Wortelboer, J. V. van Zanden, 2005, Biochemical pharmacology.